Nevro Corp. Acquires Vyrsa Technologies

Neurealm Acquires Veersa to Expand Healthcare & Agentic AI Capabilities

June 1, 2026

AI & Machine Learning

Neurealm, an AI-first technology services company backed by Kedaara Capital, announced the acquisition of Veersa. The deal expands Neurealm’s healthcare portfolio and accelerates its push toward Agentic AI by combining Veersa’s AI modernization delivery with Neurealm’s AI platform, NeuGAIN.

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion

April 6, 2026

Healthcare Services

Neurocrine Biosciences entered into a definitive agreement to acquire Soleno Therapeutics in an all-cash transaction valued at approximately $2.9 billion. The deal adds Soleno’s first-in-class therapy VYKAT XR (diazoxide choline) for hyperphagia in Prader-Willi syndrome to Neurocrine’s commercial portfolio, and is expected to close within 90 days subject to customary conditions and regulatory approvals.

Globus Medical To Acquire Nevro for $250 Million

February 15, 2025

Medical Devices

Globus Medical entered into a definitive agreement to acquire Nevro in an all-cash transaction valued at approximately $250 million (at $5.85 per share). The deal was unanimously approved by both companies’ boards and is expected to close late in the second quarter of 2025, subject to shareholder and regulatory approvals and customary closing conditions.

Gyrus Capital Leads $68M Equity Investment in Neo Medical

September 17, 2024

Medical Devices

Swiss private equity firm Gyrus Capital led a strategic equity investment of up to $68 million (CHF 58 million) into Swiss medical-technology company Neo Medical SA, with participation from existing investors including Swisscom Ventures, Verve Ventures, 4FO and Credit Suisse Entrepreneur Capital as well as the founders. The financing will fund Neo Medical’s US expansion, deployment of new spine surgery products, and further development of its AI-driven augmented reality intraoperative platform ADVISE.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Certara Acquires Vyasa Analytics

January 4, 2023

AI & Machine Learning

Certara, Inc. (Nasdaq: CERT) has acquired Vyasa Analytics, LLC to integrate Vyasa’s deep-learning platform LAYAR and AI capabilities into Certara’s biosimulation software suite. The acquisition expands Certara’s data fabric and AI-driven prediction capabilities to accelerate drug discovery and development.